Home > Name List By g > Gestonorone caproate Macao

CAS No 1253-28-7 , Gestonorone caproate Search by region : Macao

  • Name: Gestonorone caproate
  • Synonyms: Gestronol caproate; Gestronol hexanoate;Gestonorone caproate; 17-Hydroxy-19-norpregn-4-ene-3,20-dione hexanoate;Primostat;
  • CAS Registry Number:
  • Flash Point: 228.4°C
  • Boiling Point: 535.4°Cat760mmHg
  • Density: 1.11
  • Refractive index: 1.534
  • Safety Statements: Poison by intramuscular route. Experimental reproductive effects. A steroid. When heated to decomposition it emits acrid smoke and irritating fumes.
  • Flash Point: 228.4°C
  • EINECS: 215-010-2
  • Molecular Weight: 414.58
  • InChI: InChI=1/C26H38O4/c1-4-5-6-7-24(29)30-26(17(2)27)15-13-23-22-10-8-18-16-19(28)9-11-20(18)21(22)12-14-25(23,26)3/h16,20-23H,4-15H2,1-3H3/t20-,21+,22+,23-,25-,26-/m0/s1
  • Molecular Formula: C26H38O4
  • Molecular Structure:CAS No:1253-28-7 Gestonorone caproate

Select to

1253-28-7 19-Norpregn-4-ene-3,20-dione,17-[(1-oxohexyl)oxy]-

Contact Supplier

Select to

References of Gestonorone caproate
Title: Gestonorone Caproate
CAS Registry Number: 1253-28-7
CAS Name: 17-[(1-Oxohexyl)oxy]-19-norpregn-4-ene-3,20-dione
Synonyms: 17-hydroxy-19-norpregn-4-ene-3,20-dione hexanoate; 17a-hydroxy-19-norprogesterone caproate; 17b-acetyl-17-hydroxyestr-4-ene-3-one hexanoate; gestronol caproate
Manufacturers' Codes: SH-582
Trademarks: Depostat (Schering AG)
Molecular Formula: C26H38O4
Molecular Weight: 414.58
Percent Composition: C 75.32%, H 9.24%, O 15.44%
Literature References: Prepn: Popper et al., Arzneim.-Forsch. 19, 352 (1969); Popper et al., DE 1074582 (1960 to Schering). Pharmacological studies: Junkmann, Anglo-Ger. Med. Rev. 1, 385 (1962). Metabolism: Breuer, Lisboa, Acta Endocrinol. 51, 114 (1966).
Properties: Crystals, mp 123-124°. [a]D +13° (chloroform). uv max: 239 nm (e 17540).
Melting point: mp 123-124°
Optical Rotation: [a]D +13° (chloroform)
Absorption maximum: uv max: 239 nm (e 17540)
Therap-Cat: Progestogen; in treatment of prostatic hypertrophy.
Keywords: Antiprostatic Hypertrophy; Progestogen.